Activity of hydrogel-vitamin D3/bacterioruberin nanoparticles on imiquimod-induced fibroblasts-keratinocytes spheroids YR Simioni, F Ricatti, AG Salvay, HE Jerez, P Schilrreff, EL Romero, ... Journal of Drug Delivery Science and Technology 97, 105738, 2024 | | 2024 |
Evaluating the potential of ethyl cellulose/eudragit-based griseofulvin loaded nanosponge matrix for topical antifungal drug delivery in a sustained release pattern P Sengupta, A Das, J Khanam, A Biswas, J Mathew, PK Mondal, ... International Journal of Biological Macromolecules, 133953, 2024 | | 2024 |
When nanomedicines meet tropical diseases EL Romero, K Van Bocxlaer, FR Formiga Beilstein Journal of Nanotechnology 15 (1), 830-832, 2024 | | 2024 |
Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent HE Jerez, YR Simioni, K Ghosal, MJ Morilla, EL Romero Beilstein Journal of Nanotechnology 15 (1), 517-534, 2024 | | 2024 |
Nanomedicines against Chagas disease: a critical review MJ Morilla, K Ghosal, EL Romero Beilstein Journal of Nanotechnology 15 (1), 333-349, 2024 | 2 | 2024 |
Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description MJ Altube, N Perez, EL Romero, MJ Morilla, LH Higa, AP Perez International Journal of Pharmaceutics 642, 123146, 2023 | 4 | 2023 |
Cationic starch: A functionalized polysaccharide based polymer for advancement of drug delivery and health care system-A review S Chatterjee, S Mahmood, AR Hilles, S Thomas, S Roy, V Provaznik, ... International Journal of Biological Macromolecules, 125757, 2023 | 17 | 2023 |
More than pigments: The potential of astaxanthin and bacterioruberin-based nanomedicines MJ Morilla, K Ghosal, EL Romero Pharmaceutics 15 (7), 1828, 2023 | 12 | 2023 |
Macrophage-Targeted Nanomedicines EL Romero, MJ Altube, AP Perez, MJ Morilla Biotechnology Applied to Inflammatory Diseases: Cellular Mechanisms and …, 2023 | 2 | 2023 |
Ether lipids from archaeas in nano-drug delivery and vaccination EL Romero, MJ Morilla International Journal of Pharmaceutics 634, 122632, 2023 | 14 | 2023 |
More Than Pigments: The Potential of Astaxanthin and Bacterioruberin-Based Nanomedicines. Pharmaceutics 2023, 15, 1828 MJ Morilla, K Ghosal, EL Romero | 1 | 2023 |
Photodynamic therapy with nebulized nanocurcumin on A549 cells, model vessels, macrophages and beyond MJ Altube, EN Caputo, MN Rivero, ML Gutiérrez, EL Romero Pharmaceutics 14 (12), 2637, 2022 | 4 | 2022 |
In vitro anti-melanoma activity of imiquimod in ultradeformable nanovesicles AT Caimi, C Ramirez, AP Perez, EL Romero, MJ Morilla Drug Development and Industrial Pharmacy 48 (11), 657-666, 2022 | 1 | 2022 |
Improved stability and biological activity of bacterioruberin in nanovesicles AT Caimi, O Yasynska, PCR Rojas, EL Romero, MJ Morilla Journal of Drug Delivery Science and Technology 77, 103896, 2022 | 5 | 2022 |
Nanoarchaeosomes in Drug Delivery EL Romero, MJ Morilla Pharmaceutical Nanobiotechnology for Targeted Therapy, 149-186, 2022 | | 2022 |
Thymus vulgaris essential oil+ tobramycin within nanostructured archaeolipid carriers: A new approach against Pseudomonas aeruginosa biofilms N Perez, MJ Altube, LRS Barbosa, EL Romero, AP Perez Phytomedicine 102, 154179, 2022 | 7 | 2022 |
Enhancing the anti-psoriatic activity of vitamin D3 employing nanostructured archaeolipid carriers YR Simioni, NS Perez, LRS Barbosa, AP Perez, P Schilrreff, EL Romero, ... Journal of Drug Delivery Science and Technology 73, 103455, 2022 | 9 | 2022 |
The anti-inflammatory effect of nanoarchaeosomes on human endothelial cells N Charó, H Jerez, S Tatti, EL Romero, M Schattner Pharmaceutics 14 (4), 736, 2022 | 8 | 2022 |
Photodynamic Therapy with Nebulized Nanocurcumin on A549 Cells, Model Vessels, Macrophages and Beyond. Pharmaceutics 2022, 14, 2637 MJ Altube, EN Caputo, MN Rivero, ML Gutiérrez, EL Romero s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells. Pharmaceutics 2022, 14, 736 N Charó, H Jerez, S Tatti, EL Romero, M Schattner s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |